The quest for the holy grail: new antitubercular chemical entities, targets and strategies

Tuberculosis (TB) remains the leading cause of death from an infectious disease worldwide. TB therapy is complicated by the protracted treatment regimens, development of resistance coupled with toxicity and insufficient sterilizing capacity of current drugs. Although considerable progress has been m...

Descripción completa

Detalles Bibliográficos
Autores principales: Huszár, Stanislav, Chibale, Kelly, Singh, Vinayak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215093/
https://www.ncbi.nlm.nih.gov/pubmed/32062007
http://dx.doi.org/10.1016/j.drudis.2020.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215093/
https://www.ncbi.nlm.nih.gov/pubmed/32062007
http://dx.doi.org/10.1016/j.drudis.2020.02.003

Ejemplares similares